You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic Breast Cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial in Dallas (DB-1303, Capecitabine, Paclitaxel)

Not yet recruiting
  • Metastatic Breast Cancer
  • Dallas, Texas
    Texas Oncology - Baylor Charles A. Sammons Cancer Center
Aug 25, 2023

Her 2 Positive Breast Cancer, Breast Cancer Female, Breast Cancer Metastatic Trial in Boston (Sacituzumab Govitecan,

Not yet recruiting
  • Her 2 Positive Breast Cancer
  • +2 more
  • Sacituzumab Govitecan
  • +2 more
  • Boston, Massachusetts
  • +1 more
Oct 25, 2023

HER2-positive Breast Cancer Trial in Shanghai (68Ga/131I-SGMIB-5F7)

Not yet recruiting
  • HER2-positive Breast Cancer
  • 68Ga/131I-SGMIB-5F7
  • Shanghai, China
    Huashan Hospital
Aug 1, 2023

Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (SPH4336 Tablets, SPH4336 Tablets Placebo)

Not yet recruiting
  • Locally Advanced or Metastatic Breast Cancer
  • SPH4336 Tablets
  • SPH4336 Tablets Placebo
  • Guangzhou, Guangdong, China
    Affiliated Cancer Hospital, Sun Yat-sen University
May 8, 2023

Metastatic Breast Cancer-Specific Prognostic Tool

Recruiting
  • Metastatic Breast Cancer
  • Patients and Caregivers Qualitative Interview
  • Chapel Hill, North Carolina
    Terri Eubanks
Oct 7, 2022

HER2-positive Breast Cancer, LMD Trial (Tucatinib 150 MG, Trastuzumab, Capecitabine)

Not yet recruiting
  • HER2-positive Breast Cancer
  • LMD
  • Tucatinib 150 MG
  • +3 more
  • (no location specified)
Aug 24, 2023

HER2-low in Metastatic Breast Cancer Patients

Not yet recruiting
  • HER2-negative
    • (no location specified)
    Nov 9, 2023

    HR Positive/HER2 Low Expression Metastatic Breast Cancer Trial in Guangzhou, Shantou, Qionghai (Disitamab vedotin, Endocrine

    Recruiting
    • HR Positive/HER2 Low Expression Metastatic Breast Cancer
    • Disitamab vedotin
    • Endocrine therapy
    • Guangzhou, Guangdong, China
    • +2 more
    Jun 19, 2023

    Metastatic Breast Cancer Trial in Milwaukee (Lifestyle Intervention)

    Recruiting
    • Metastatic Breast Cancer
    • Lifestyle Intervention
    • Attention Control
    • Milwaukee, Wisconsin
      Medical College of Wisconsin
    Dec 16, 2022

    Metastatic Breast Cancer, Hyperinsulinism, Hyperglycemia Drug Induced Trial in Haifa (Pioglitazone)

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Haifa, Israel
      Rambam Health Care Campus
    Feb 22, 2023

    Triple Negative Breast Cancer, Metastatic Breast Cancer Trial (Sacituzumab govitecan)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Metastatic Breast Cancer
    • Sacituzumab govitecan
    • (no location specified)
    Jan 23, 2023

    Metastatic Breast Cancer Trial in Pompano Beach, Caracas (ConvitVax)

    Not yet recruiting
    • Metastatic Breast Cancer
    • ConvitVax
    • Pompano Beach, Florida
    • +2 more
    Aug 28, 2023

    Advanced or Metastatic Breast Cancer Trial (PF-07220060, Fulvestrant, Everolimus)

    Not yet recruiting
    • Advanced or Metastatic Breast Cancer
    • (no location specified)
    Oct 24, 2023

    HER2 Low Advanced or Metastatic Breast Cancer Trial (SHR-A1811 & Dalpiciclib Isethionate Tablets, SHR-A1811 & Fulvestrant,

    Not yet recruiting
    • HER2 Low Advanced or Metastatic Breast Cancer
    • SHR-A1811 & Dalpiciclib Isethionate Tablets
    • +2 more
    • (no location specified)
    Mar 19, 2023

    Breast Cancer Trial in Chengdu (Dalpiciclib combined with Letrozole)

    Not yet recruiting
    • Breast Cancer
    • Dalpiciclib combined with Letrozole
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Aug 3, 2023

    Breast Cancer Trial (SHR-A1811 for injection ; capecitabine)

    Not yet recruiting
    • Breast Cancer
    • SHR-A1811 for injection ; capecitabine
    • (no location specified)
    May 4, 2023

    Breast Cancer Trial in Nanjing (Inetetamab, Pyrotinib, Oral Vinorelbine Tartrate)

    Recruiting
    • Breast Cancer
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Apr 10, 2023

    Breast Cancer Trial in Xi'an (Inetetamab plus pyrotiniband and capecitabine)

    Active, not recruiting
    • Breast Cancer
    • Inetetamab plus pyrotiniband and capecitabine
    • Xi'an, Shaanxi, China
      Xi'an International Medical Center Hospital
    Aug 27, 2023

    Triple-Negative Breast Cancer Trial in Shanghai (VEGFR, nab-paclitaxel, Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin)

    Recruiting
    • Triple-Negative Breast Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Mar 28, 2023

    Metastatic Breast Cancer (MBC) Trial in Nanjing, Shanghai (Paclitaxel Polymeric Micelles for Injection, Eribulin Mesilate

    Recruiting
    • Metastatic Breast Cancer (MBC)
    • Paclitaxel Polymeric Micelles for Injection
    • +5 more
    • Nanjing, Jiangsu, China
    • +2 more
    Nov 21, 2023

    Metastatic Breast Cancer Trial in Taipei City, Taipei, Yuanlin (Olaparib, Chemotherapy drug)

    Recruiting
    • Metastatic Breast Cancer
    • Taipei City, Please Select, Taiwan
    • +2 more
    Nov 27, 2022

    Metastatic Breast Cancer Trial in Charlottesville (HER2 BATs with Pembrolizumab)

    Recruiting
    • Metastatic Breast Cancer
    • HER2 BATs with Pembrolizumab
    • Charlottesville, Virginia
      Ashley Donihee
    Jan 18, 2023

    Compare Overall Survival in Medicare Metastatic Breast Cancer

    Active, not recruiting
    • Breast Cancer
    • New York, New York
      Pfizer New York
    Oct 11, 2023

    Metastatic Cancer, Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer Trial (OB-002)

    Not yet recruiting
    • Metastatic Cancer
    • +5 more
    • (no location specified)
    Jul 10, 2023

    Metastatic Breast Cancer Trial in Seoul (Fulvestrant plus AI plus ribociclib, AI plus ribociclib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Fulvestrant plus AI plus ribociclib
    • AI plus ribociclib
    • Seoul, Korea, Republic of
      Korea university Guro hospital
    Apr 16, 2023